Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 96,699
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12589154 | Acid type sophorolipid-containing composition which is suppressed in browning | 🖼🧊📄§ | 2026-03-31 | 2040-01-15 | 0 | 31 |
| 12589155 | Efficient synthesis of lipid-fluorescein conjugates for CAR-T cell therapy | 🖼🧊📄§ | 2026-03-31 | 2040-07-02 | 0 | 31 |
| 12589157 | Compositions of drug delivery agents and methods of use thereof | 🖼🧊📄§ | 2026-03-31 | 2039-03-29 | 0 | 31 |
| 12589156 | Benzimidazole and benzimidazolone based protac compounds for the targeted degradation of leucine rich repeat kinase 2 (LRRK2) | 🖼🧊📄§ | 2026-03-31 | 2045-03-24 | 0 | 31 |
| 12589159 | CD71 binding fibronectin type III domains | 🖼🧊📄§ | 2026-03-31 | 2043-02-27 | 0 | 31 |
| 12589160 | Peptide-derived therapeutics targeting KDM5C for the treatment of cancer | 🖼🧊📄§ | 2026-03-31 | 2040-03-12 | 0 | 31 |
| 12589163 | Shedding blocking agents with increased stability | 🖼🧊📄§ | 2026-03-31 | 2041-03-11 | 0 | 31 |
| 12589161 | PEGylated synthetic KL4 peptide, compositions and methods thereof | 🖼🧊📄§ | 2026-03-31 | 2040-07-10 | 0 | 31 |
| 12589162 | Trans-cyclooctene prodrug of monomethyl auristatin E | 🖼🧊📄§ | 2026-03-31 | 2041-08-06 | 0 | 31 |
| 12589165 | Methods for treating bladder tumors with viral nanoparticle conjugates and immune checkpoint inhibitors | 🖼🧊📄§ | 2026-03-31 | 2038-04-11 | 0 | 31 |
| 12589166 | Compositions and methods for treating wounds | 🖼🧊📄§ | 2026-03-31 | 2041-05-13 | 0 | 31 |
| 12589170 | Devices and methods for radiopharmaceutical synthesis | 🖼🧊📄§ | 2026-03-31 | 2040-04-07 | 0 | 31 |
| 12589169 | Compound and MRI contrast agent containing same | 🖼🧊📄§ | 2026-03-31 | 2041-10-05 | 0 | 31 |
| 12589171 | 177-Lu labeled peptide for site-specific uPAR-targeting | 🖼🧊📄§ | 2026-03-31 | 2041-01-07 | 0 | 31 |
| 12589182 | Occlusive implant compositions | 🖼🧊📄§ | 2026-03-31 | 2043-12-29 | 0 | 31 |
| 12589075 | Osmotic dosage forms comprising deutetrabenazine and methods of use thereof | 🖼🧊📄§ | 2026-03-31 | 2044-03-19 | 0 | 31 |
| 12589076 | Gelatin capsules with ground calcium carbonate | 🖼🧊📄§ | 2026-03-31 | 2040-10-08 | 0 | 31 |
| 12589074 | Tablets having discontinuous coated regions | 🖼🧊📄§ | 2026-03-31 | 2043-01-05 | 0 | 31 |
| 12589073 | Leveraging lipid-protein interactions to engineer spatial organization in cell-free systems | 🖼🧊📄§ | 2026-03-31 | 2042-11-09 | 0 | 31 |
| 12589066 | Cosmetic composition containing an extract from opuntia ficus indica | 🖼🧊📄§ | 2026-03-31 | 2040-11-02 | 0 | 31 |
| 12589065 | Hair care system, hair care method and use of a hair care system | 🖼🧊📄§ | 2026-03-31 | 2039-01-17 | 0 | 31 |
| 12589069 | Ophthalmic suspension composition | 🖼🧊📄§ | 2026-03-31 | 2042-12-21 | 0 | 31 |
| 12589071 | Suckable and/or melt-in-mouth tablet based on hyaluronic acid and chondroitin sulphate and salts thereof | 🖼🧊📄§ | 2026-03-31 | 2044-02-26 | 0 | 31 |
| 12589068 | Contraceptive medical devices | 🖼🧊📄§ | 2026-03-31 | 2040-11-11 | 0 | 31 |
| 12589072 | Bioadhesive film and methods of use thereof | 🖼🧊📄§ | 2026-03-31 | 2041-11-11 | 0 | 31 |
| 12589063 | Composition comprising a combination of two particular oxidation dye precursors, an amphoteric or zwitterionic surfactant and a solid fatty substance | 🖼🧊📄§ | 2026-03-31 | 2042-10-27 | 0 | 31 |
| 12589062 | Powdery solid cosmetic preparation | 🖼🧊📄§ | 2026-03-31 | 2040-12-18 | 0 | 31 |
| 12589057 | Cosmetic composition of liquid crystal lipid particles for personal care applications | 🖼🧊📄§ | 2026-03-31 | 2040-01-27 | 0 | 31 |
| 12589060 | Bleaching powder composition | 🖼🧊📄§ | 2026-03-31 | 2040-10-30 | 0 | 31 |
| 12589059 | Mineral sunscreen compositions with high SPF and shelf stability | 🖼🧊📄§ | 2026-03-31 | 2041-09-30 | 0 | 31 |
| 12589056 | Curable composition for dental impression | 🖼🧊📄§ | 2026-03-31 | 2040-11-19 | 0 | 31 |
| 12589055 | Dental composition | 🖼🧊📄§ | 2026-03-31 | 2040-09-10 | 0 | 31 |
| 12588675 | Synergistic antibacterial activity of medium polarity oils in combination with antibacterial agents on bacterial biofilms | 🖼🧊📄§ | 2026-03-31 | 2043-04-03 | 0 | 31 |
| 12588693 | Composition for producing hydrogen rich water and other products | 🖼🧊📄§ | 2026-03-31 | 2037-07-17 | 0 | 31 |
| 12588689 | Feed additive composition containing erythritol | 🖼🧊📄§ | 2026-03-31 | 2041-09-07 | 0 | 31 |
| 12588863 | Systems and methods for preventing and treating wrinkles | 🖼🧊📄§ | 2026-03-31 | 2044-05-15 | 0 | 31 |
| 12590134 | GLP-1 agonist polypeptide compound and salt thereof, synthesis method therefor and use thereof | 🖼🧊📄§ | 2026-03-31 | 2042-08-17 | 0 | 31 |
| 12590129 | Liver-specific regulatory nucleic acid sequences | 🖼🧊📄§ | 2026-03-31 | 2039-11-19 | 0 | 31 |
| 12590153 | Treatment of PD-L1-negative melanoma using an anti-PD-1 antibody and an anti-CTLA-4 antibody | 🖼🧊📄§ | 2026-03-31 | 2041-11-10 | 0 | 31 |
| 12589147 | Multivalent HVT vector vaccine | 🖼🧊📄§ | 2026-03-31 | 2040-12-18 | 0 | 31 |
| 12589070 | Low-dosage orodispersible opioid tablet and method for preparing same | 🖼🧊📄§ | 2026-03-31 | 2040-08-13 | 0 | 31 |
| 12589153 | Polyurethane excipient | 🖼🧊📄§ | 2026-03-31 | 2044-12-17 | 0 | 31 |
| 12589148 | Immunity-inducing agent comprising antigen peptide-adjuvant nucleotide conjugate and pharmaceutical composition comprising same | 🖼🧊📄§ | 2026-03-31 | 2039-09-27 | 0 | 31 |
| 12589189 | Use of retinoic acid receptor (RAR) agonists for reversing, preventing, or delaying calcification of aortic valve | 🖼🧊📄§ | 2026-03-31 | 2040-10-01 | 0 | 31 |
| 12589145 | Systems to produce B cells genetically modified to express selected antibodies | 🖼🧊📄§ | 2026-03-31 | 2043-02-08 | 0 | 31 |
| 12589168 | Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems | 🖼🧊📄§ | 2026-03-31 | 2042-04-29 | 0 | 31 |
| 12589077 | Method for preparing biodegradable microcapsules and microcapsules thus obtained | 🖼🧊📄§ | 2026-03-31 | 2041-11-18 | 0 | 31 |
| 12589135 | Topical administration of GLP-1 receptor agonists | 🖼🧊📄§ | 2026-03-31 | 2043-08-21 | 0 | 31 |
| 12589110 | Carbonated aerosol external preparation for skin | 🖼🧊📄§ | 2026-03-31 | 2041-10-01 | 0 | 31 |
| 12589134 | Compositions and methods of use of interleukin-10 in combination with immune check-point pathway inhibitors | 🖼🧊📄§ | 2026-03-31 | 2043-10-17 | 0 | 31 |